Lena Mårtensson Wernrud
Directeur/Membre du Conseil chez Oncorena AB
Profil
Lena Mårtensson Wernrud is currently a Director at Oncorena AB.
Previously, she worked as an Independent Director at Genovis AB, Senior Director-Pipeline Sourcing at LEO Pharma A, and Director at Oncorena Holding AB.
She also worked as an Associate Professor at the University of Lund.
Dr. Wernrud holds a doctorate degree from the University of Lund, and graduate degrees from the University of Southern Denmark and The University of Colorado School of Medicine.
Postes actifs de Lena Mårtensson Wernrud
| Sociétés | Poste | Début |
|---|---|---|
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Directeur/Membre du Conseil | - |
Anciens postes connus de Lena Mårtensson Wernrud
| Sociétés | Poste | Fin |
|---|---|---|
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Directeur/Membre du Conseil | - |
| University of Lund | Corporate Officer/Principal | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - |
| GENOVIS AB | Directeur/Membre du Conseil | - |
Formation de Lena Mårtensson Wernrud
| University of Lund | Doctorate Degree |
| The University of Colorado School of Medicine | Graduate Degree |
| University of Southern Denmark | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENOVIS AB | Health Technology |
| Entreprise privées | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
